The announcement of an acquisition to complement Ergomed’s pharmacovigilance division, PrimeVigilance, comes as no surprise given Ergomed stated that it was evaluating potential service business acquisitions at the time of its interim results. PharmInvent, a European pharmacovigilance and regulatory services business, will be integrated with PrimeVigilance, which continues to generate impressive growth (+53% in H1 2016). The acquisition will be immediately accretive to earnings. Ergomed’s strate ....
29 Nov 2016
N+1 Singer - Ergomed - PharmInvent acquisition complements PrimeVigilance
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - Ergomed - PharmInvent acquisition complements PrimeVigilance
- Published:
29 Nov 2016 -
Author:
Sheena Berry -
Pages:
3
The announcement of an acquisition to complement Ergomed’s pharmacovigilance division, PrimeVigilance, comes as no surprise given Ergomed stated that it was evaluating potential service business acquisitions at the time of its interim results. PharmInvent, a European pharmacovigilance and regulatory services business, will be integrated with PrimeVigilance, which continues to generate impressive growth (+53% in H1 2016). The acquisition will be immediately accretive to earnings. Ergomed’s strate ....